Related Experiment Video
Updated: Oct 12, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Acrodermatitis continua of Hallopeau in a patient with myelodysplastic syndrome
P C van der Kerkhof1, P M Steijlen, R A Raymakers
1Department of Dermatology, University Hospital, Nijmegan, Netherlands.
Insights
Acrodermatitis continua of Hallopeau (ACH) is a rare psoriasis manifestation. Acitretin effectively treated ACH but transformed myelodysplastic syndrome (MDS) into acute myeloid leukemia, necessitating caution with retinoids in MDS patients.
Area of Science:
- Dermatology
- Hematology
- Oncology
Background:
- Acrodermatitis continua of Hallopeau (ACH) is a rare, debilitating pustular psoriasis variant.
- Myelodysplastic syndrome (MDS) is a group of clonal hematopoietic stem cell disorders.
Observation:
- This case report details a patient with ACH and MDS treated with acitretin.
- Acitretin demonstrated efficacy in managing ACH symptoms.
- The patient developed acute myeloid leukemia (AML) during acitretin therapy.
Findings:
- Retinoids, including acitretin, can impact bone marrow function in normal subjects, MDS patients, and AML patients.
- The transformation of MDS to AML occurred during acitretin treatment.
- Available literature and this case suggest caution when using aromatic retinoids in MDS patients.
Implications:
- Aromatic retinoids like acitretin and etretinate are not recommended for patients with MDS.
- If retinoid treatment is necessary for MDS patients, intensive hematological monitoring is crucial.
- This highlights the potential risks of retinoids in patients with pre-existing bone marrow disorders.
Abstract:
Acrodermatitis continua of Hallopeau (ACH) is a rare manifestation of pustular psoriasis which may considerably disable affected patients. In this case report we confirm the efficacy of acitretin in the treatment of ACH and, in addition, describe the course of the myelodysplastic syndrome (MDS) from which the patient was suffering. During acitretin treatment, there was a transformation into acute myeloid leukaemia. We discuss the effect of retinoids on the bone marrow of normal subjects, patients with MDS, and patients with acute myeloid leukaemia. Our experience in the present case, and the information from the available literature, lead us to advise against the use of the aromatic retinoids, acitretin and etretinate, in patients with MDS. If such treatment is indicated, intensive haematological supervision is mandatory.
Related Concept Videos
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

